A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma
暂无分享,去创建一个
C. Balañà | P. Pérez-Segura | O. Gallego | M. Gil-Gil | J. Capellades | A. Berrocal | G. Reynés | J. Sepúlveda | C. Belda-Iniesta | J. M. Ordóñez | B. Orden